Advertisement

Topics

Catalyst OrthoScience Inc. Company Profile

17:55 EDT 21st September 2018 | BioPortfolio

Catalyst OrthoScience develops and markets surgical implants that make orthopedic surgery less invasive and more efficient for both surgeons and patients. Catalyst was founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., who saw the need to make shoulder replacement surgery less invasive and give patients a more natural-feeling shoulder after surgery.


News Articles [286 Associated News Articles listed on BioPortfolio]

Catalyst OrthoScience Adds Brian K. Hutchison to Board of Directors as Executive Chair, Interim CEO

Catalyst OrthoScience Inc., a cutting-edge medical device company focused on the upper extremity orthopedics market, today announced the addition of Brian K. Hutchison to its boa...

A simple catalyst helps to assemble complex molecular frameworks of antifungal agents

(AKSON Russian Science Communication Association) A team of Russian chemists led by Professor Dmitry Perekalin from Nesmeyanov Institute of Organoelement Compounds have recently developed a new rhodiu...

Angel Capital Association Names Outstanding Startups as Finalists for Luis Villalobos Innovation and Ingenuity Award

National Award Finalists are Catalyst OrthoScience, CNote, PhotoniCare, and Oculogica KANSAS CITY, Mo. (PRWEB) April 11, 2018 The Angel Capital Association (ACA), the world's largest professional...

Catalyst seeks FDA nod for Lambert-Eaton myasthenic syndrome therapy

Catalyst Pharmaceuticals filed a new drug application with the FDA seeking approval for Firdapse, or amifampridine, which is  -More- 

A ruthenium-based catalyst with highly active, flat surfaces outperforms metal-based competitors

Scientists in Japan and India have developed a reusable, high-performance catalyst based on flat-shaped ruthenium nanoparticles (Ru-NP) for the production of valuable chemicals. Due to its demonstrate...

Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromusc...

Catalyst Pharmaceuticals enrols first patient in MSK-002 trial

Catalyst Pharmaceuticals has enrolled the first patient in its MSK-002 trial, a Phase III clinical study evaluating the efficacy and...Read More... The post Catalyst Pharmaceuticals enrols first patie...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Catalyst Biosciences, Inc. - CBIO

NEW YORK, June 18, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Catalyst Biosciences, Inc. ("Catalyst" or the "Company") (NASDAQ: CBIO). Such investors are ...

Drugs and Medications [0 Results]

None

PubMed Articles [440 Associated PubMed Articles listed on BioPortfolio]

Silicon carbide foam supported ZSM-5 composite catalyst for microwave-assisted pyrolysis of biomass.

Considering a series of issues facing the application of catalysts in large scale catalytic fast pyrolysis systems, a novel composite catalyst of ZSM-5 coatings on SiC foam supports was developed and ...

Microwave-assisted catalytic pyrolysis of moso bamboo for high syngas production.

Microwave-assisted pyrolysis of moso bamboo with the activated carbon-supported iron(III) ion catalyst was carried out with the aim of obtaining high quality and quantity syngas(H + CO). The effec...

Selective CO Evolution from Photoreduction of CO2 on a Metal-Carbide-Based Composite Catalyst.

A selective CO evolution from photoreduction of CO2 in wa-ter was achieved on a noble-metal-free, carbide-based compo-site catalyst, as demonstrated by a CO selectivity of 98.3% among all carbon-conta...

Excellent activity and selectivity of one-pot synthesized Cu-SSZ-13 catalyst in the selective catalytic oxidation of ammonia to nitrogen.

One-pot synthesized Cu-SSZ-13 catalyst treated with dilute HNO3 achieved superior activity and selectivity in the selective catalytic oxidation (SCO) of NH3 to nitrogen, in comparison with other zeoli...

Planar-chiral rhodium(III) catalyst with sterically demanding cyclopentadienyl ligand and its application for enantioselective synthesis of dihydroisoquinolones.

Rapid development of enantioselective CH-activation reactions created a demand for new types of catalysts. Herein we report the synthesis of a novel planar-chiral rhodium catalyst [(C5H2tBu2CH2tBu)RhI...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

Basic Knowledge of CPR Among Close Relatives of Heart Patients-check Status Quo and Attemp to Establish a Potential Plan to Implement This Knowledge

Cardiac arrest is a public health problem and is the leading cause of death in many parts of the world. Cardiac arrest can occur inside the hospital and outside it. In the United States a...

Companies [106 Associated Companies listed on BioPortfolio]

Catalyst OrthoScience Inc.

Catalyst OrthoScience develops and markets surgical implants that make orthopedic surgery less invasive and more efficient for both surgeons and patients. Catalyst was founded in ...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

Catalyst Advisors

Catalyst Advisors is a premier executive search firm devoted to finding exceptional boardroom and executive leaders for innovative healthcare and bioscience companies, including t...

Catalyst Advisors, L.P.

Catalyst Advisors helps high-growth life sciences companies identify and attract the transformative board members, CEOs and other senior leaders needed to successfully navigate cr...

More Information about "Catalyst OrthoScience Inc." on BioPortfolio

We have published hundreds of Catalyst OrthoScience Inc. news stories on BioPortfolio along with dozens of Catalyst OrthoScience Inc. Clinical Trials and PubMed Articles about Catalyst OrthoScience Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst OrthoScience Inc. Companies in our database. You can also find out about relevant Catalyst OrthoScience Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...


Corporate Database Quicklinks



Searches Linking to this Company Record